SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpool Corporation is facing intense downward pressure driven by a major guidance cut, a surprise dividend suspension, and weak earnings reports that management has attributed to macroeconomic volatility and cooling consumer demand. The community is sharply divided, with many investors debating whether the stock is a deep-value opportunity or a failing brand in a death spiral, while others highlight significant institutional concerns regarding high debt levels and operational management.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to anticipation surrounding upcoming clinical data presentations and an influx of institutional buying, while investors actively debate the potential for a short squeeze given the elevated short interest. Sentiment remains polarized as the community weighs speculative biotech potential against concerns over cash burn and clinical trial timelines.

Aventus Network

Aventus Network is facing significant community frustration following a sharp decline in price, compounded by reports of technical glitches on Coinbase that are preventing users from placing buy orders. While some investors are concerned about a potential rug pull, others remain focused on the project's long-term utility, specifically regarding its recent cloud infrastructure developments and enterprise blockchain solutions.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing intense selling pressure and negative sentiment as investors grapple with its long-term downtrend and lackluster price performance compared to broader crypto market recoveries. While some community members remain deeply committed, citing long-term potential in real-world asset tokenization and enterprise partnerships, many others are expressing frustration over stagnant volume and are warning of further potential downside.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending as investors weigh strong cash reserves and aggressive buybacks against a volatile e-commerce landscape and ongoing regulatory pressures. The community remains divided, with some highlighting the stock's deep undervaluation and long-term potential, while others caution against the persistent selling pressure and the broader geopolitical risks associated with Chinese ADRs.

Happen, Inc. is a U.S. digital marketplace bank focused on the Motivated Middle high FICO, high-income borrowers actively managing their financial lives. The firm’s success is fueled by advanced credit underwriting, a proprietary technology platform, and a marketplace bank model that generates compelling revenue through loan sales, net interest income, and fee-based services. It operates through the LendingClub Bank and LendingClub Corporation (Parent Only) segments. The LendingClub Bank segment is involved in the provision of a full complement of financial products and solutions, loans, leases, and deposits. The LendingClub Corporation (Parent Only) segment includes the holding company legal entity. The company was founded by Renaud Laplanche and Soulaiman Htite on October 2, 2006 and is headquartered in San Francisco, CA.

Happen Inc.

Happen Inc. is capturing market attention following a solid earnings report and a strategic shift in corporate identity, fueling discussions around its AI-driven operational efficiency and strong cash position. Investors are actively debating the company's valuation, recent share buyback activity, and its growth prospects relative to other digital finance platforms.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is trending as institutional investors closely watch its upcoming earnings report following a series of strategic pipeline expansions and strong performance from high-growth drugs like Repatha. The community remains focused on the potential competitive impact of its late-stage obesity candidate, MariTide, and the company's broader efforts to balance patent cliffs with innovation.

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Zoetis Inc - Ordinary Shares - Class A

Zoetis is trending as investors digest news of a strategic partnership with Danone to pioneer sustainable dairy farming through genetics while monitoring technical support levels near its 52-week lows. The community remains divided, with some investors aggressively accumulating on the dip as a long-term value play, while others voice frustration over recent price volatility and ongoing sector-wide performance concerns.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending as investors weigh persistent macroeconomic headwinds against potential bullish setups heading into its quarterly earnings, while the community intensely debates the stock's future amid shifting interest rate expectations and housing market concerns.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuity is trending following a successful Phase 3 trial readout that demonstrated significant progression-free survival benefits for its lead asset, gedatolisib, in PIK3CA-mutant breast cancer patients. Investors are actively discussing the stock's transition to a commercial-stage company, recent institutional accumulation, and the potential for a strategic acquisition by a larger pharmaceutical partner given the drug's strong clinical data and substantial market opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
